Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug ...Middle East

PR Newswire - News
STOCKHOLM, March 2, 2021 /PRNewswire/ -- Oscotec Inc. (039200: KOSDAQ), the Korean drug development company, and Beactica Therapeutics AB, the Swedish drug discovery company, today announced a new research development and licensing agreement. Oscotec and Beactica will initially jointly...

Hence then, the article about oscotec and beactica therapeutics announce license and collaboration agreement to develop new cancer drug was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News